Product Information
QC ANTI-DIARRHEAL 2 MG SOFTGEL is a generic product labeled by Chain Drug Marketing Association, priced at $0.1363 per EA under NDC 83324020924. Its NADAC has been published 63 times since Jul 23, 2025.
FDA first approved this application on Aug 4, 2005.
Strength
2 mg/1
Manufacturer
Chain Drug Marketing AssociationNDC
83324020924
Classification
Generic
Dosage Form
CAPSULE, LIQUID FILLED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LOPERAMIDE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA021855FDA Approved
8/4/2005
On Market Since
5/21/2025
Pharmacological Classes
Price Statistics
The NADAC for QC ANTI-DIARRHEAL 2 MG SOFTGEL has been published 63 times since Jul 23, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1363 per EA |
|---|---|
| All-time high | $0.1363 (Sep 30, 2026) |
| All-time low | $0.1329 (Dec 17, 2025) |
| 52-week high | $0.1363 |
| 52-week low | $0.1329 |
| Median price | $0.1346 |
| Average price | $0.1346 |
| Largest weekly change | -1.2% (May 20, 2026) |
| Weeks tracked | 63 |
| Tracking since | Jul 23, 2025 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 60% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chain Drug Marketing Association manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
LOPERAMIDE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of QC ANTI-DIARRHEAL 2 MG SOFTGEL?
The current National Average Drug Acquisition Cost (NADAC) for QC ANTI-DIARRHEAL 2 MG SOFTGEL, manufactured by Chain Drug Marketing Association, is $0.1363 per EA (NDC 83324020924), effective Sep 30, 2026.
How has the price of QC ANTI-DIARRHEAL 2 MG SOFTGEL changed over time?
Over the history we have for it, the NADAC for QC ANTI-DIARRHEAL 2 MG SOFTGEL has held within roughly two percent of its current level. It has been tracked across 63 weekly CMS publications since Jul 23, 2025.
What are the highest and lowest recorded NADAC prices for QC ANTI-DIARRHEAL 2 MG SOFTGEL?
Since Jul 23, 2025, the NADAC for QC ANTI-DIARRHEAL 2 MG SOFTGEL has ranged from a low of $0.1329 (Dec 17, 2025) to a high of $0.1363 (Sep 30, 2026), with a median of $0.1346 per EA.
Are there cheaper alternatives to QC ANTI-DIARRHEAL 2 MG SOFTGEL?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LOPERAMIDE 2 MG CAPSULE, is $0.0549 per EA — about 60% below QC ANTI-DIARRHEAL 2 MG SOFTGEL.
Who manufactures QC ANTI-DIARRHEAL 2 MG SOFTGEL?
QC ANTI-DIARRHEAL 2 MG SOFTGEL (NDC 83324020924) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.